• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE; DEVICE IMPOTENCE MECHANICAL/HYDRAULIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE; DEVICE IMPOTENCE MECHANICAL/HYDRAULIC Back to Search Results
Model Number 72404264
Medical Device Problem Codes Difficult or Delayed Activation (2577); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Pain (1994)
Date of Event 03/25/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Date of event: exact date is unknown.There was no device available for analysis and there was no report of a device performance allegation during treatment.The reported patient symptoms are known risk associated with implants of these device as indicated in the instructions for use (ifu).The device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event or Problem Description
It was reported that the patient experienced pain around the scrotum when pumping his inflatable penile prosthesis (ipp) pump multiple times.There were no device issues reported.A revision surgery has not been scheduled.
 
Additional Manufacturer Narrative
This supplemental report was not able to be submitted on-time by boston scientific because of delayed acknowledgments from fda for the initial report.An fda system issue resulted in the delayed acknowledgements.This report will not be considered late, because it was the result of an fda system issue.B3 date of event: exact date is unknown.There was no device available for analysis and there was no report of a device performance allegation during treatment.The reported patient symptoms are known risk associated with implants of these device as indicated in the instructions for use (ifu).The device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event or Problem Description
It was reported that the patient experienced pain around the scrotum when pumping his inflatable penile prosthesis (ipp) pump multiple times.The pump exhibited activation issues.The patient underwent a revision surgery to reposition the pump.There were no further patient complications.
 
Additional Manufacturer Narrative
There was no device available for analysis and there was no report of a device performance allegation during treatment.The reported patient symptoms are known risk associated with implants of these device as indicated in the instructions for use (ifu).The device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event or Problem Description
It was reported that the patient experienced pain around the scrotum when pumping his inflatable penile prosthesis (ipp) pump multiple times.The pump exhibited activation issues.The patient underwent a revision surgery in which the pump and cylinders were explanted and replaced.Boston scientific has been unable to obtain additional information regarding the patient outcome to date, despite good faith efforts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMS INFLATABLE PENILE PROSTHESIS WITH INHIBIZONE
Common Device Name
DEVICE IMPOTENCE MECHANICAL/HYDRAULIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key16506858
Report Number2124215-2023-10780
Device Sequence Number3352100
Product Code FHW
UDI-Device Identifier00878953003726
UDI-Public00878953003726
Combination Product (Y/N)Y
Initial Reporter CountryAS
PMA/510(K) Number
N970012
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2022
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Consumer
Initial Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date09/02/2022
Device Model Number72404264
Device Catalogue Number72404264
Device Lot Number1000452806
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/16/2023
Supplement Date Received by Manufacturer03/14/2023
02/18/2024
Initial Report FDA Received Date03/08/2023
Supplement Report FDA Received Date04/28/2023
02/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured09/02/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-0427-2021
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
RESERVOIR UPN72404155/LOT1000588411
Outcome Attributed to Adverse Event Other; Required Intervention; Hospitalization;
Patient Age65 YR
Patient SexMale
-
-